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Abstract  508 
Subcortical brain structures are integral to motion, consciousness, emotions, and 509 
learning. We identified common genetic variation related to the volumes of nucleus 510 
accumbens, amygdala, brainstem, caudate nucleus, globus pallidus, putamen, and thalamus, 511 
using genome-wide association analyses in almost 40,000 individuals from CHARGE, 512 
ENIGMA and the UK-Biobank. We show that variability in subcortical volumes is heritable, 513 
and identify 48 significantly associated loci (40 novel at the time of analysis). Annotation of 514 
these loci utilizing gene expression, methylation, and neuropathological data identified 199 515 
genes putatively implicated in neurodevelopment, synaptic signaling, axonal transport, 516 
apoptosis, inflammation/infection, and susceptibility to neurological disorders. This set of 517 
genes is significantly enriched for Drosophila orthologs associated with 518 
neurodevelopmental phenotypes, suggesting evolutionarily conserved mechanisms. Our 519 
findings uncover novel biology and potential drug targets underlying brain development 520 
and disease. 521 
  522 
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Subcortical brain structures are essential for the control of autonomic and 523 
sensorimotor functions1,2, modulation of processes involved in learning, memory, and 524 
decision-making3,4, as well as in emotional reactivity5,6 and consciousness7. They often act 525 
through networks influencing input to and output from the cerebral cortex8,9. The 526 
pathology of many cognitive, psychiatric, and movement disorders is restricted to, begins 527 
in, or predominantly involves subcortical brain structures and related circuitries10. For 528 
instance, tau pathology has shown to manifest itself early in the brainstem of individuals 529 
with Alzheimer’s disease before spreading to cortical areas through efferent networks11. 530 
Similarly, the formation of Lewy bodies and Lewy neurites in Parkinson’s disease appears 531 
early in the lower brainstem (and olfactory structures) before affecting the substantia 532 
nigra12.  533 
Recent investigations have identified genetic loci influencing the volumes of the 534 
putamen, caudate, and pallidum, which pointed to genes controlling neurodevelopment 535 
and learning, apoptosis, and transport of metals13,14. However, a larger study combining 536 
these samples, which include individuals of a broad age-range across diverse studies, 537 
would enable increased power to identify additional novel genetic variants contributing to 538 
variability in subcortical structures, and further improve our understanding of brain 539 
development and disease. 540 
We sought to identify novel genetic variants influencing the volumes of seven subcortical 541 
structures (nucleus accumbens, amygdala, caudate nucleus, putamen, globus pallidus, 542 
thalamus, and brainstem – including mesencephalon, pons, and medulla oblongata), 543 
through genome-wide association (GWA) analyses in almost 40,000 individuals from 53 544 
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study samples (Supplementary Table 1-3) from the Cohorts of Heart and Aging Research in 545 
Genomic Epidemiology (CHARGE) consortium, the Enhancing Neuro Imaging Genetics 546 
through Meta-Analysis (ENIGMA) consortium, and the United Kingdom Biobank (UKBB). 547 
 548 
RESULTS 549 
 550 
Heritability 551 
To examine the extent to which genetic variation accounts for variation in subcortical 552 
brain volumes, we estimated their heritability in two family-based cohorts: the 553 
Framingham Heart Study (FHS) and the Austrian Stroke Prevention Study (ASPS-Fam). Our 554 
analyses are in line with previous studies conducted in twins15, suggesting that variability 555 
in subcortical volumes is moderately to highly heritable. The structures with highest 556 
heritability in the FHS and the ASPS-Fam are the brainstem (ranging from 79-86%), 557 
caudate nucleus (71-85%), putamen (71-79%) and nucleus accumbens (66%); followed by 558 
the globus pallidus (55-60%), thalamus (47-54%), and amygdala (34-59%) (Figure 1, 559 
Supplementary Table 4). We additionally estimated SNP-based heritability using GCTA in 560 
the Rotterdam Study, and LD score regression (LDSC) in the full European sample. As 561 
expected, SNP-based heritability estimates were somewhat lower, ranging from 47% for 562 
the thalamus to 17% for the amygdala using GCTA, and ranging from 33% for the 563 
brainstem to 9% for the amygdala using LDSC. These values are consistent with heritability 564 
estimates reported by the UKBB14. 565 
 566 
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Genome-wide associations 567 
We undertook a GWA analysis on the MRI-derived volumes of subcortical structures 568 
using the 1000 Genomes Project16 reference panel (phase 1 v.3) for imputation of missing 569 
variants in CHARGE and ENIGMA. The UKBB performed imputation of variants using the 570 
HRC reference panel17 (see details on image acquisition and genotyping in Supplementary 571 
Table 5 and Supplementary Table 6, respectively). Our sample comprised up to n = 37,741 572 
individuals of European ancestry from 48 study samples across CHARGE, ENIGMA and the 573 
UKBB. Additionally, we included three samples for generalization in African-Americans (up 574 
to n = 769), and two for generalization in Asians (n = 341). Details on the population 575 
characteristics, definition of the outcome and genotyping can be found in the supplement 576 
(Supplementary Tables 2-5). Each study examined the association of genetic variants with 577 
minor allele frequency (MAF) ≥1% to the volumes of subcortical structures (average 578 
volume for bilateral structures) using additive genetic models adjusted for sex, age, total 579 
intracranial volume (or total brain volume in the UKBB); as well as age2, population 580 
structure, psychiatric diagnosis (ENIGMA cohorts), and study site when applicable. After 581 
quality control, we conducted meta-analyses per ethnicity combining all samples using 582 
sample-size-weighted fixed effects methods in METAL18. An analysis of genetic correlations 583 
showed consistency of associations across the CHARGE-ENIGMA and the UKBB (rg > 0.94; P 584 
< 1.46 × 10-15), demonstrating the similar genetic architecture of subcortical volumes in 585 
these two datasets. 586 
We identified 48 independent genome-wide significant single nucleotide 587 
polymorphisms (SNPs) across all seven subcortical structures, 40 of which are novel at the 588 
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time of analysis (Table 1). Among these, 26 SNPs were located within genes (one missense, 589 
25 intronic), and 22 in intergenic regions. Most of the inflation observed in the quantile 590 
plots (Supplementary Figure 1) is due to polygenic effects. We carried forward these 48 591 
SNPs for in-silico generalization in African-American and Asian samples, and performed a 592 
combined meta-analysis of all samples (Supplementary Table 7). Of the 46 SNPs present in 593 
the generalization samples, the direction of association was the same for 13 across all 594 
ethnicities and for an additional 6 SNPs in either the African-American or the Asian 595 
samples. In the combined meta-analysis, 43 of the 48 associations remained significant, and 596 
for 21 SNPs, the strength of association increased when all samples were combined. 597 
Although we did not find significant associations for most SNPs at the generalization 598 
sample level, likely due to their limited sample size, the sign test for the direction of effect 599 
suggested that a large proportion of the SNPs associated with subcortical volumes in the 600 
European sample are also associated in the African-American and Asian samples at the 601 
polygenic level (P < 1 × 10-4 ; Supplementary Table 8).  602 
To functionally annotate the 48 SNPs identified in the European sample, we used Locus 603 
Zoom19, investigated expression quantitative trait loci (eQTL) and methylation QTL 604 
(meQTL) in post-mortem brains from the Religious Order Study and the Rush Memory and 605 
Aging Project (ROSMAP), and also queried cis- and trans-eQTL datasets in brain and non-606 
brain tissues for the top 48 SNPs or their proxies (r2>0.8), using the European population 607 
reference (Supplementary Tables 9-12). Lead variants and their proxies were annotated to 608 
genes based on the combination of physical proximity, eQTL and meQTL, which in some 609 
instances assigned more than one gene to a single SNP. Most of our index SNPs had genes 610 
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assigned based on more than one functional source. This strategy allowed us to identify 611 
199 putatively associated genes (Supplementary Table 13). More details can be found in 612 
the Supplementary note. 613 
 614 
Associations with cognition and neuropathology 615 
Although individual SNPs were not related to neuro-pathological traits or cognitive 616 
function in ROSMAP (Supplementary Table 14), we found that cortical mRNA expression of 617 
12 of our putatively associated genes was associated with neuropathological alterations 618 
typically observed in Alzheimer’s Disease (Supplementary Table 15). These included β-619 
amyloid load / presence of neuritic plaques (APOBR, FAM65C, KTN1, NUPR1, OPA1) and tau 620 
density / neurofibrillary tangles (FAM65C, MEPCE, OPA1, STAT1). Many of these genes, 621 
together with ANKRD42, BCL2L1, RAET1G, SGTB, and ZCCHC14, were also related to 622 
cognitive function. 623 
 624 
Phenotypic and genetic correlations 625 
We explored both phenotypic (Supplementary Table 16) and genetic (Supplementary 626 
Table 17) correlations among subcortical volumes. We also investigated genetic 627 
correlations of subcortical volumes with traits previously examined in the CHARGE and 628 
ENIGMA consortia, including MRI-defined brain volumes20,21,22, stroke subtypes23, 629 
anthropometric traits24, general cognitive function25, Alzheimer’s disease26, Parkinson’s 630 
Disease27, bipolar disorder and schizophrenia28, and attention deficit/hyperactivity 631 
disorder (ADHD)29. We observed strong phenotypic and genetic overlap among most 632 
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subcortical structures using LDSC methods, consistent with our finding that many of the 633 
loci identified have pleiotropic effects on the volumes of several subcortical structures.  634 
As expected, we found strong genetic correlations among the nuclei composing the 635 
striatum, particularly for nucleus accumbens with caudate nucleus (P = 9.83 × 10-19), and 636 
with putamen (P = 1.02 × 10-17). The genetic architecture of thalamic volume highly 637 
overlapped with that of most subcortical volumes, except for the caudate nucleus. In 638 
contrast, there were no significant genetic correlations for the volume of the brainstem 639 
with that of most structures, with the exception of very strong correlations with volumes of 640 
the thalamus (P = 1.56  × 10-22) and the globus pallidus (P = 1.52 × 10-21). Individual level 641 
analyses using GCTA in the Rotterdam Study (n = 3,486) showed similar correlations 642 
despite the smaller sample. 643 
We also observed strong genetic correlations for hippocampal volumes with amygdalar 644 
and thalamic volumes. Height correlated with thalamic volumes and volume of the 645 
brainstem was inversely correlated with ADHD. Notably, caudate nucleus volumes 646 
correlated with white matter hyperintensity burden. 647 
 648 
Cross-species analysis  649 
To investigate for potential evolutionarily conserved requirements of our gene-set in 650 
neurodevelopment, neuronal maintenance, or both, we examined available genetic and 651 
phenotypic data from the fruit fly, Drosophila melanogaster. Importantly, compared to 652 
mammalian models, the fly genome has been more comprehensively interrogated for roles 653 
in the nervous system. We found that a large proportion of candidate genes for human 654 
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subcortical volumes are strongly conserved in the Drosophila genome (59%), and many of 655 
these genes appear to have conserved nervous system requirements (Supplementary Table 656 
18). To examine if this degree of conservation was greater than that expected by chance, 657 
we leveraged systematic, standardized phenotype data based on FlyBase annotations using 658 
controlled vocabulary terms. Indeed, 22% of the conserved fly homologs are documented 659 
to cause “neuroanatomy defective” phenotypes in flies, representing a significant (P = 7.3 × 660 
10-4), nearly two-fold enrichment compared to 12.9% representing all Drosophila genes 661 
associated with such phenotypes (Supplementary Table 19). 662 
 663 
Partitioning heritability 664 
We further investigated enrichment for functional categories of the genome using 665 
stratified LDSC methods30 (Figure 2). Super enhancers were significantly enriched in most 666 
subcortical structures, with 17% of SNPs explaining 43% of SNP-heritability in the 667 
brainstem, 39% in the caudate, 44% in the pallidum, 37% in the putamen, and 38% in the 668 
thalamus.  Similarly, strong enrichment was observed for regular enhancers (H3K27ac 669 
annotations from Hnisz31) in several subcortical structures, explaining over 60% of their 670 
SNP-heritability. Conserved regions were enriched in the nucleus accumbens and the 671 
brainstem, with 2.6% of SNPs explaining 53% and 35% of their SNP heritability, 672 
respectively. Finally, only the brainstem showed enrichment for transcription start sites 673 
(TSS), with 1.8% of SNPs explaining 26% of this structure SNP-heritability. Full results are 674 
presented in Supplementary Table 20. 675 
 676 
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Protein-protein interactions 677 
To explore potential functional relationships between proteins encoded by our set of genes, 678 
we conducted protein-protein interaction analyses in STRING32. Our results showed 679 
enrichment of genes involved in brain-specific pathways (i.e. regulation of neuronal death 680 
and neuronal apoptosis), as well as immune-related (i.e. antigen processing, Epstein-Barr 681 
virus infection) and housekeeping processes (i.e. proteasome, cell differentiation, 682 
signaling). Figure 3 shows these protein networks, and the detailed pathways are 683 
presented in Supplementary Table 21.   684 
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DISCUSSION 685 
We undertook the largest GWA meta-analysis of variants associated with MRI-derived 686 
volumes of the nucleus accumbens, amygdala, brainstem, caudate nucleus, globus pallidus, 687 
putamen, and thalamus; in almost 40,000 individuals from 53 study samples worldwide. 688 
Our analyses identified a set of 199 candidate genes influencing the volume of these 689 
subcortical brain structures, most of which have relevant roles in the nervous system. 690 
Our results show wide overlap of genetic variants determining the volume of 691 
subcortical structures as elucidated from genetic correlations and individual look-ups 692 
among structures. We find that 26 candidate genes may influence more than one structure. 693 
For instance, significant SNPs near KTN1, are also associated with the volume of the 694 
nucleus accumbens, caudate nucleus, and globus pallidus, suggesting that this genomic 695 
region may have an important role in determining multiple subcortical brain volumes 696 
during development. Furthermore, 14 of the candidate genes were associated with the 697 
caudate, globus pallidus and putamen, supporting the shared genetic architecture of the 698 
functionally defined corpus striatum. 699 
We identified genes implicated in neurodevelopment. We confirm the 11q14.3 genomic 700 
region near the FAT3 gene, previously associated with the caudate nucleus13, additionally 701 
associated with the putamen in our analysis. This gene encodes a conserved cellular 702 
adhesion molecule implicated in neuronal morphogenesis and cell migration based on 703 
mouse genetic studies33. SNPs near PBX3 were associated with caudate volume. PBX3 is 704 
robustly expressed in the developing caudate nucleus of the non-human primate, Macaca 705 
fuscata, consistent with a role in striatal neurogenesis34.  706 
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We found several genes involved in insulin/IGF1 signaling, including IGF1, PAPPA, 707 
GRB10, SH2B1 and TXNDC5 across the amygdala, brainstem, caudate, and putamen. PAPPA 708 
encodes a secreted metalloproteinase that cleaves IGFBPs, thereby releasing bound IGF. 709 
Although IGF may be beneficial in early- and midlife, its effects may be detrimental during 710 
aging. Studies of PAPPA similarly support antagonistic pleiotropy. Low circulating PAPPA 711 
levels are a marker for adverse outcomes in human embryonic development35, but in later 712 
life, higher levels have been associated with acute coronary syndromes and heart 713 
failure36,37. Further, Grb10 and SH2B1 act as regulators of insulin/IGF1 signaling through 714 
their SH2 domains38. Finally, TXNDC5 has been suggested to increase IGF1 activity by 715 
inhibiting the expression IGFBP1 in the context of rheumatoid arthritis39.  716 
Additional genes related to neurodevelopment include PTPN1 (brainstem), ALPL and 717 
NBPF3, (both related to the globus pallidus), and SLC20A2 (nucleus accumbens). In studies 718 
of both human and mouse embryonic stem cells, PTPN1 was implicated as a critical 719 
regulator of neural differentiation40. In addition, PTPN1 encodes a target for the 720 
transcriptional regulator encoded by MECP2, which causes the neurodevelopmental 721 
disorder Rett Syndrome, and inhibition of PTPB1 is being explored as a therapeutic 722 
strategy in mouse Rett models41. ALPL mediates neuronal differentiation early during 723 
development and post-natal synaptogenesis in transgenic mouse models42. ALPL may also 724 
help propagate the neurotoxicity induced by tau43, and its activity increases in Alzheimer’s 725 
disease44 and cognitive impairment45. NBPF3 belongs to the neuroblastoma breakpoint 726 
family, which encodes domains of the autism- and schizophrenia-related DUF1220 727 
protein46. SLC20A2, related to the globus pallidus and the thalamus, encodes an inorganic 728 
Satizabal et al. 
 
34 
 
phosphate transporter for which more than 40 mutations have been described in 729 
association with familial idiopathic basal ganglia calcification (Fahr’s Syndrome)47,48. It is 730 
interesting to note that other three solute carrier genes were identified in this GWA 731 
(SLC12A9, SLC25A29, SLC39A8), suggesting that the molecular transport of metals, amino 732 
acids, and other solutes across the cellular membrane could play an important role in the 733 
development of subcortical brain structures. 734 
Several genes were related to synaptic signaling pathways. We found a SNP in NPTX1 735 
related to the thalamus, a gene expressed in the nervous system which restricts synapse 736 
plasticity49, and induces β-amyloid neurodegeneration in human and mouse brain tissues50. 737 
Additionally, the identified an intronic SNP in SGTB for the brainstem, which was an eQTL 738 
for the expression of SGTB in dorsolateral prefrontal cortex. Experimental rat models 739 
showed that βSGT, highly expressed in brain, forms a complex with the cysteine string 740 
protein and heat-shock protein cognate (CSP/Hsc70) complex to function as a chaperone 741 
guiding the refolding of misfolded proteins near synaptic vesicles51. Other experimental 742 
studies in C. elegans, showed that the genetic manipulation of the ortholog, sgt-1, 743 
suppresses toxicity associated with expression of the human β-amyloid peptide52. Other 744 
genes involved in synaptic signaling are CHPT1 (brainstem), involved in 745 
phosphatidylcholine metabolism in the brain; KATNA1(brainstem), a conserved regulator 746 
of neuronal process formation, outgrowth, and synaptogenesis53,54; and DLG2 (putamen), 747 
encoding an evolutionarily conserved scaffolding protein involved in glutamatergic-748 
mediated synaptic signaling and cell polarity55 that has been associated with 749 
schizophrenia56, cognitive impairment57, and Parkinson’s disease58.  750 
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Another set of SNPs point to genes involved in autophagy and apoptotic processes, 751 
such as DRAM1 and FOXO3, both related to brainstem volumes. DRAM1 encodes a 752 
lysosomal membrane protein involved in activating TP53-mediated autophagy and 753 
apoptosis,59 and mouse models mimicking cerebral ischemia and reperfusion have found 754 
that inhibiting the expression of DRAM1 worsens cell injury60. The top SNP was also 755 
associated with a CpG site proximate to active TSS upstream of DRAM1 in several mature 756 
brain tissues (S3.6). FOXO3 has been recently identified as pivotal in an astrocyte network 757 
conserved across humans and mice involved in stress, sleep, and Huntington's disease61, 758 
and has been related to longevity62. In Drosophila, a FOXO3 ortholog regulates dendrite 759 
number and length in the peripheral nervous system63, and in the zebrafish, Danio rario, 760 
Foxo3a knockdown led to apoptosis and mispatterning of the embryonic CNS64. Additional 761 
genes involved in apoptotic processes are BCL2L1 (globus pallidus and putamen), BIRC6 762 
(globus pallidus) and OPA1 (brainstem). 763 
Other genes have been implicated in axonal transport. We confirm the association 764 
between the 13q22 locus near KTN1 with putamen volume13and expand by showing that 765 
this region is also associated with the nucleus accumbens, caudate and the globus pallidus . 766 
The most significant SNP (rs945270) is a robust eQTL for KTN1 in peripheral blood cells. 767 
This gene encodes a kinesin-binding protein involved in the transport of cellular 768 
components along microtubules65, and impairment of these molecular motors has been 769 
increasingly recognized in neurological diseases with a subcortical component66. The 5q12 770 
locus upstream from MAST4 was associated with nucleus accumbens volume. MAST4 771 
encodes a member of the microtubule-associated serine/threonine kinases. This gene has 772 
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been associated with hippocampal volumes20 and juvenile myoclonic epilepsy67,and it 773 
appears to be differentially expressed in the prefrontal cortex of atypical cases of 774 
frontotemporal lobar degeneration68. In Drosophila, the knockdown of a conserved MAST4 775 
homolog enhanced the neurotoxicity of human tau69, which aggregates to form 776 
neurofibrillary tangle pathology in Alzheimer’s disease. Further, we identified SNPs near 777 
NEFL and NEFM (globus pallidus), where the top SNP was an eQTL for these genes in 778 
subcortical brain tissue and esophagus mucosa. NEFL encodes the light chain, and NEFM 779 
the medium chain of the neurofilament. These proteins determine neuronal caliber and 780 
conduction velocity70. Mutations in NEFL/M genes have been related to neuropsychiatric 781 
disorders and both proteins are increasingly recognized as powerful biomarkers of 782 
neurodegeneration71. 783 
Finally, several of our candidate genes are also involved in inflammation, immunity 784 
and infection (ANKRD42, DEFB124, IL27, NLRC4, PILRA/B, TRIM23, TRIM4), in line with the 785 
PPI analysis highlighting the KEGG-Epstein-Barr virus infection pathway. This suggests that 786 
immune-related processes may be an important determinant influencing subcortical 787 
volumes, as has been shown by other GWAS of neurologic traits72,73. 788 
 789 
Overall, the loci identified by our study pinpoint candidate genes not only associated 790 
with human subcortical brain volumes, but also reported to disrupt invertebrate 791 
neuroanatomy when manipulated in Drosophila and many other animal models. Thus, our 792 
results are in line with the knowledge that the genomic architecture of central nervous 793 
system development has been strongly conserved during evolution. Partitioning 794 
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heritability results suggest the nucleus accumbens and the brainstem are particularly 795 
enriched in conserved regions.  796 
 797 
One of the main limitations of our study was the small size of our generalization 798 
samples, which limits the generalizability of our results to non-European ethnicities. 799 
However, our analyses suggest significant concordance for the direction of effect across all 800 
ethnicities at the polygenic level. We hope diverse samples become increasingly available 801 
to further confirm our findings and make new discoveries. Additionally, we have focused 802 
on the discovery of common and less frequent variants. Further efforts to also reveal rare 803 
variants and epigenetic signatures associated with subcortical structures will provide an 804 
even more refined understanding of the underlying mechanisms involved. 805 
 806 
In conclusion, we describe multiple genes associated with the volumes of MRI-derived 807 
subcortical structures in a large sample, leveraging diverse bioinformatic resources to 808 
validation and follow-up our findings. Our analyses indicate that the variability of 809 
evolutionarily old subcortical volumes of humans is moderately to strongly heritable, and 810 
that their genetic variation is also strongly conserved across different species. The majority 811 
of the variants identified in this analysis point to genes involved in neurodevelopment, 812 
regulation of neuronal apoptotic processes, synaptic signaling, axonal transport, 813 
inflammation/immunity, and susceptibility to neurological disorders. We show that the 814 
genetic architecture of subcortical volumes overlaps with that of anthropometric measures 815 
and neuropsychiatric disorders. In summary, our findings greatly expand current 816 
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understanding of the genetic variation related to subcortical structures, which can help 817 
identify novel biological pathways of relevance to human brain development and disease. 818 
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Figure 1. Heritability and Manhattan plot of genetic variants associated with subcortical brain volumes in the 1025 
European sample. 1026 
 1027 
a. Family-based heritability (h2) estimates were performed with SOLAR in the Framingham Heart Study (n = 895) and the 1028 
Austrian Stroke Prevention-Family Study (n = 370). b. Combined Manhattan plot highlighting the most significant SNPs across 1029 
all subcortical structures (nucleus accumbens = 32,562; amygdala = 34,431; brainstem = 28,809; caudate = 37,741; pallidum = 1030 
34,413; putamen = 37,571; thalamus = 34,464). Variants are colored differently for each structure (see legend in a). Linear 1031 
regression models were adjusted for sex, age, age², total intracranial volume (CHARGE) or total brain volume (UKBB), and 1032 
population stratification. The solid horizontal line denotes genome-wide significance as set in this study after additional 1033 
Bonferroni correction for six independent traits (P <5 × 10-8/6 = 8.3 × 10-9 for two-sided tests), the dashed horizontal line 1034 
denotes the classic genome-wide threshold of P < 5 × 10-8. Individual Manhattan plots can be found in the Supplementary note. 1035 
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Figure 2. Partitioning heritability by functional annotation categories.  1036 
 1037 
Analyses performed in the European sample (nucleus accumbens = 32,562; amygdala = 34,431; brainstem =28,809; caudate = 1038 
37,741; pallidum = 34,413; putamen = 37,571; thalamus = 34,464). Plotted ellipses represent enrichment (proportion of h2g 1039 
explained / proportion of SNPs in a given functional category) for subcortical structures (y-axis) across 28 functional 1040 
categories (x-axis). The color bar indicates the magnitude and direction of enrichment. Starred pairs denote significant over-1041 
representation after Bonferroni correction for 168 tests (28 annotation categories and 6 independent traits, P < 3 × 10-4).  1042 
DHS, DNase I hypersensitivity site; TSS, transcription start site.1043 
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Figure 3. Protein-protein interaction network of 158 genes enriched for common variants influencing the volume of 1044 
subcortical structures.  1045 
 1046 
The edges represent protein-protein associations, where the edge color indicates the predicted mode of action (bright green, 1047 
activation; pink, posttranslational modification; red, inhibition; dark blue, binding, purple, catalysis; light blue, phenotype; 1048 
black, reaction; yellow, transcriptional regulation) and the edge shape the predicted action effects (arrow, positive, flat arrow, 1049 
negative; oval arrow, unspecified). Colored nodes represent the queried proteins and first shell of interactors (5 maximum), 1050 
whereas white nodes represent the second shell of interactors (5 maximum). 1051 
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Table 1. Genome-wide associationa results for subcortical brain volumes in Europeans from CHARGE, ENIGMA, and the UKBB 1052 
SNP Chr Position Function A1/A2 A1 Freq. Weight Z-score Pb Direction I² 
Nucleus accumbens (n=32,562)  
rs9818981c 3 190602087 intergenic A/G 0.09 32,282 -6.23 4.70E-10 --- 63.2
rs13107325 4 103188709 missense T/C 0.06 32,283 6.15 7.74E-10 +++ 76.2
rs11747514c 5 65839259 intronic T/G 0.22 32,562 -5.99 2.11E-09 --- 0.0
rs868202c 14 56195762 intergenic T/C 0.56 32,562 5.90 3.55E-09 +++ 0.0
Amygdala (n=34,431)  
rs11111293c 12 102921296 intergenic T/C 0.78 34,313 6.25 4.16E-10 +++ 0.0
Brainstem (n=28,809)  
rs11111090 12 102326461 intergenic A/C 0.52 28,809 10.79 3.70E-27 +++ 0.0
rs10217651c 9 118923652 intronic A/G 0.39 28,809 9.78 1.40E-22 +++ 0.0
rs869640c 5 65015128 intronic A/C 0.72 28,809 -8.40 4.36E-17 --- 9.5
rs9398173c 6 109000316 intronic T/C 0.33 28,809 -7.95 1.80E-15 --- 19.0
rs10792032c 11 68984602 intergenic A/G 0.49 28,648 7.75 9.08E-15 +++ 39.4
rs4396983c 4 15132604 intergenic A/G 0.44 28,809 -7.02 2.27E-12 --- 73.6
rs9322194c 6 149920249 intronic T/C 0.34 28,156 6.91 4.94E-12 +++ 0.0
rs7972561c 12 107139983 intronic A/T 0.33 28,809 6.90 5.05E-12 +++ 0.0
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rs2206656c 20 49130119 intronic C/G 0.61 28,809 6.83 8.26E-12 +++ 0.0
rs12479469c 20 61145196 intergenic A/G 0.33 25,822 -6.80 1.08E-11 --- 65.6
rs4784256c 16 52814559 intergenic A/G 0.40 28,809 6.76 1.41E-11 +++ 0.0
rs555925c 3 193544359 intergenic T/G 0.41 27,934 6.37 1.88E-10 +++ 62.9
rs12313279c 12 102846504 intronic A/G 0.29 28,809 6.21 5.39E-10 +++ 24.9
rs9505301c 6 7887131 intronic A/G 0.89 28,691 -6.05 1.41E-09 --- 43.2
rs11684404c 2 88924622 intronic T/C 0.66 28,809 -5.95 2.73E-09 --- 0.0
rs112178027c 17 27564013 intergenic T/C 0.17 28,809 -5.90 3.67E-09 --- 0.0
Caudate nucleus (n=37,741)  
rs3133370 11 92026446 intergenic T/C 0.67 37,741 7.52 5.59E-14 +++ 44.9
rs6060983c 20 30420924 intronic T/C 0.70 37,741 7.04 1.95E-12 +++ 0.0
rs7040561c 9 128528978 intronic A/T 0.85 34,049 -6.26 3.84E-10 --- 0.0
rs2817145c 1 3133422 intronic A/T 0.19 35,598 6.20 5.71E-10 +++ 65.3
rs148470213c 14 56193700 intergenic T/C 0.54 29,429 6.18 6.48E-10 ++? 0.0
rs1987471c 16 28825866 intergenic T/G 0.63 37,741 5.87 4.40E-09 +++ 0.0
rs12445022c 16 87575332 intergenic A/G 0.33 37,741 5.87 4.45E-09 +++ 0.0
rs55989340c 14 100635222 intergenic A/G 0.74 37,741 -5.86 4.62E-09 --- 52.0
rs4888010c 16 73895046 intergenic A/G 0.47 37,741 5.86 4.67E-09 +++ 74.9
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rs35305377c 7 99938955 intronic A/G 0.55 33,429 -5.84 5.36E-09 --- 47.8
Globus pallidus (n=34,413)  
rs2923447 8 42439848 intergenic T/G 0.59 34,413 8.11 4.88E-16 +++ 34.0
rs10129414c 14 56193272 intergenic A/G 0.44 34,413 -7.53 5.11E-14 --- 0.0
rs196807c 8 24682649 intergenic A/G 0.18 34,295 6.44 1.17E-10 +++ 21.1
rs10439607c 20 30258541 intronic A/G 0.30 34,413 -6.28 3.35E-10 --- 0.0
rs4952211c 2 32611512 intronic T/C 0.43 34,252 -5.86 4.72E-09 --- 61.9
rs12567402c 1 21870213 intronic T/C 0.33 34,214 5.81 6.17E-09 +++ 0.0
Putamen (n=37,571)  
rs945270 14 56200473 intergenic C/G 0.58 37,571 15.03 5.02E-51 +++ 57.3
rs62098013 18 50863861 intronic A/G 0.38 37,571 8.92 4.59E-19 +++ 33.9
rs6087771 20 30306724 intronic T/C 0.71 36,291 8.69 3.75E-18 +++ 7.5
rs35200015c 11 117383215 intronic A/G 0.19 37,571 -8.19 2.51E-16 --- 0.0
rs1432054 11 83260225 intronic A/G 0.64 37,571 -7.94 2.10E-15 --- 0.0
rs7902527c 10 118715399 intronic A/G 0.24 37,108 6.29 3.13E-10 +++ 0.0
rs2244479c 7 50738987 intronic T/C 0.65 36,291 -5.92 3.17E-09 --- 32.1
rs2410767c 5 87705268 intronic C/G 0.78 37,571 5.88 3.99E-09 +++ 0.0
rs1187162c 11 92011126 intergenic T/C 0.42 37,571 5.84 5.14E-09 +++ 0.0
Satizabal et al. 
 
55 
 
Thalamus (n=34,464)   
rs12600720c 17 78448640 intronic C/G 0.69 33,023 6.25 4.06E-10 +++ 0.0
rs142461330c 7 55012097 intergenic T/C 0.92 34,185 -5.90 3.69E-09 --- 0.0
a Linear regression models are adjusted for sex, age, age², total intracranial volume (CHARGE) or total brain volume (UKBB), 1053 
and population stratification.  1054 
b P-values are two-tailed. Significance was set at P < 8.3 × 10-9 after additional Bonferroni correction for six independent traits 1055 
(5 x 10-8/6). 1056 
c Novel SNPs  1057 
Chr = chromosome; Freq. = frequency of the coded allele; A1 = coded allele; A2 = non-coded allele 1058 
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ONLINE METHODS 1059 
 1060 
Study population 1061 
The present effort included 53 study samples from the Cohorts of Heart and Aging 1062 
Research in Genomic Epidemiology (CHARGE) consortium 74, the Enhancing Neuro Imaging 1063 
Genetics through Meta-Analysis (ENIGMA) consortium75, and the United Kingdom Biobank 1064 
(UKBB)76. Briefly, the CHARGE consortium is a collaboration of predominantly population-1065 
based cohort studies investigating the genomics of age-related complex diseases, including 1066 
those of the brain (depts.washington.edu/chargeco/wiki/). The ENIGMA consortium brings 1067 
together various studies, approximately 75% of which are population-based, with the 1068 
remainder using case-control designs for various neuropsychiatric or neurodegenerative 1069 
diseases (enigma.ini.usc.edu/). The UKBB is a large-scale prospective epidemiological 1070 
study of over 500,000 individuals aged 40-69 years from the United Kingdom, established 1071 
to investigate the genetic and non-genetic determinants of middle and old age diseases 1072 
(www.ukbiobank.ac.uk/).  1073 
Our sample consisted of up to n=37,741 individuals of European ancestry. We 1074 
additionally included three generalization samples of African-Americans (up to n=769), 1075 
and two generalization samples of Asians (n=341). All participants have provided written 1076 
informed consent and participating studies obtained approval from their institutional 1077 
review board or equivalent organization. The institutional review boards of Boston 1078 
University and the University of Southern California, as well as the local ethics board of 1079 
Erasmus University Medical Center approved this study. 1080 
Satizabal et al. 
 
57 
 
Exclusion criteria comprised prevalent dementia or stroke at the time of the MRI scan, 1081 
and when available, presence of large brain infarcts or other neurological pathologies seen 1082 
at the MRI that could substantially influence the measurement of brain volumes (e.g. brain 1083 
tumor, trauma). Individual studies applied the exclusion criteria prior to analyses. 1084 
 1085 
Definition of phenotypes 1086 
Our study investigated the volumes of seven subcortical structures: nucleus accumbens, 1087 
amygdala, brainstem, caudate nucleus, globus pallidus, putamen, and thalamus. These 1088 
phenotypes were defined as the mean volume (in cm3) of the left and right hemispheres, 1089 
with the exception if the brainstem that was simply defined as total volume (in cm3). Each 1090 
study contributed magnetic resonance imaging (MRI) data obtained using diverse 1091 
scanners, field strengths, and acquisition protocols. The estimation of volumes for the 1092 
seven subcortical brain structures and total intracranial volume was generated by freely 1093 
available and in-house segmentation methods previously described and validated. 1094 
Summary statistics for subcortical brain volumes in CHARGE study samples are presented 1095 
in Supplementary Table 3, and the study-specific MRI protocols and software are described 1096 
in Supplementary Table 5. We have recently published results describing the genetic 1097 
variation associated with hippocampal volumes20, and therefore, we have not included that 1098 
brain structure in this report. 1099 
 1100 
Genotyping 1101 
Genotyping was performed using a variety of commercial arrays across the 1102 
participating studies. Study samples and genetic variants underwent similar quality control 1103 
Satizabal et al. 
 
58 
 
procedures based on genetic homogeneity, call rate, minor allele frequency (MAF), and 1104 
Hardy-Weinberg Equilibrium. Good quality variants were used as input for imputation to 1105 
the 1000 Genomes Project (phase 1, version 3) reference panel16, or the Haplotype 1106 
Reference Consortium (HRC, version 1.1)17 in the UKBB, using validated software packages. 1107 
A detailed description of the genotyping and quality control carried by each study is 1108 
described in Supplementary Table 6.  1109 
 1110 
Heritability  1111 
Heritability of subcortical brain volumes was estimated in the Framingham Heart Study 1112 
(FHS)77 and the Austrian Stroke Prevention Study Family Study (ASPS Fam)78, two 1113 
population-based cohorts with family structure. We used SOLAR79 to determine the ratio of 1114 
the genetic variance to the phenotypic variance, including variance component models that 1115 
were adjusted for age, sex, total intracranial volume, as well as age squared and principal 1116 
components if required, in the same way it is described for the genome-wide association 1117 
(GWA) analysis. We also estimated the variance of subcortical structures explained by SNPs 1118 
in a sample of n=3,486 unrelated participants from the Rotterdam Study using GCTA80, and 1119 
additionally in the full European sample using LDSC regression methods81. Supplementary 1120 
Table 4 provides family- and SNP-based heritabilities for subcortical structures.  1121 
 1122 
Genome-wide associations and meta-analysis 1123 
In CHARGE and ENIGMA, each study undertook a GWA analysis on the volumes of seven 1124 
MRI subcortical brain structures (or those that were available to each study) according to a 1125 
common predefined analysis plan. Studies including unrelated participants performed 1126 
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linear regression analyses, whereas those including related participants conducted linear 1127 
mixed models to account for familial relationships. Models assumed additive genetic effects 1128 
and were adjusted for age, sex, total intracranial volume and, if applicable, they were 1129 
additionally adjusted for age2, principal components to account for population 1130 
stratification, psychiatric diagnosis (ENIGMA cohorts), and study site. Individual studies 1131 
shared summary statistics to a centralized, secured computing space. Analysis in the UKBB 1132 
sample followed a similar approach in n=8,312 unrelated participants although the genetic 1133 
data used for these analyses uses only those variants imputed using the HRC17 reference 1134 
panel. As the data released by the UKBB did not include total intracranial volume, linear 1135 
regression models in this sample are adjusted for age, age2, sex, total brain volume, and 1136 
principal components. We used LDSC methods81 to investigate the genetic correlations for 1137 
all subcortical structures between the CHARGE-ENIGMA and the UKBB. There was no 1138 
evidence suggesting differences in the genetic architecture of both samples. 1139 
Prior to meta-analysis, we performed quality control at the study-level summary 1140 
statistics using a series of quality checks implemented in EasyQC82. Filters were set to 1141 
remove SNPs with poor imputation (R2 < 0.5), rare (MAF < 0.1%), or with an effective allele 1142 
count (2 x MAF x study sample size x imputation quality) < 20. Finally, we only considered 1143 
variants present in at least 70% of the total European sample for each structure. 1144 
Fixed-effects meta-analyses weighting for sample size were performed using METAL18, 1145 
given that not all samples used the same methods for acquisition and post-processing of 1146 
brain images. We used the LD score regression intercept to correct for population 1147 
stratification and cryptic relatedness81. Quantile and Manhattan plots are presented for 1148 
each subcortical structure in Supplementary Figure 1. To correct for multiple comparisons 1149 
Satizabal et al. 
 
60 
 
across our seven traits, we calculated the Pearson’s correlation among subcortical 1150 
structures adjusting for age, sex and intracranial volume in n=4,459 participants from the 1151 
Rotterdam Study. After 1,000 permutations, the resulting number of independent traits 1152 
was of six, leading to the definition of a significant threshold as P < (5 × 10-8/6) = 8.3 × 10-9. 1153 
To select our top independent SNPs in the European meta-analysis, we ran a multi-SNP-1154 
based conditional & joint association analysis (GCTA-COJO)80 using n=6,921 participants 1155 
from the Rotterdam Study as the reference sample. In secondary analyses, we looked for 1156 
the association of our index SNPs (the most significant variant in each locus) with the other 1157 
six subcortical structures. 1158 
We conducted separate meta-analyses by ancestry, and further performed a combined 1159 
meta-analysis including all samples. Forest plots were created to explore the contribution 1160 
of participating studies to each of the significant SNPs (Supplementary Figure 4). To assess 1161 
signal overlap with African-American and Asian samples, we first clumped variants with P 1162 
< 1 × 10-4 in the European sample, and then ran binomial sign tests for the correlation of 1163 
the direction of association across ethnic groups.  1164 
 1165 
Functional annotations  1166 
We used Locus Zoom19 based on the hg 19 UCSC Genome Browser assembly for the 1167 
visualization of the nearest genes within a ±500 Kb genomic region. We also investigated 1168 
cis (1 Mb) expression quantitative trait loci (eQTL) and methylation QTL (meQTL) for our 1169 
index SNPs in post-mortem brains from the Religious Order Study and the Rush Memory 1170 
and Aging Project (ROSMAP). In ROSMAP, the dorsolateral prefrontal cortex (DLPFC) was 1171 
selected for initial multi-omics data generation, as it is relevant to multiple common 1172 
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neuropathologies and cognitive phenotypes in the aging population83. RNA was extracted 1173 
from the gray matter of DLPFC, and next-generation RNA sequencing (RNA-Seq) was done 1174 
on the Illumina HiSeq for samples with an RNA integrity score > 5 and a quantity threshold 1175 
> 5 ug, as previously described83,84. We quantile-normalized the fragments per kilobase of 1176 
transcript per million fragments mapped (FPKM), correcting for batch effect with 1177 
Combat84,85. These adjusted FPKM values were used for analysis. A subset of 407 1178 
participants had quality-controlled RNA-Seq data and were included in the eQTL analysis.  1179 
DNA methylation levels from the gray matter of DLPFC were measured using the 1180 
Illumina HumanMethylation450 BeadChip, and the measurements underwent QC 1181 
processing as previously described (i.e. detection p < 0.01 for all samples)83, yielding 708 1182 
participants with 415,848 discrete CpG dinucleotide sites with methylation measurement. 1183 
Any missing methylation levels from any of quality-controlled CpG dinucleotide sites were 1184 
imputed using a k-nearest neighbor algorithm for k = 10083. A subset of 488 participants in 1185 
our study had quality-controlled genome-wide methylation data and were included in the 1186 
cis-methylation QTL analysis. Finally, the associations between our index SNPs and CpG 1187 
sites were plotted along Roadmap Epigenomic chromatin states for ten brain tissues86.  1188 
We further queried cis and trans eQTLs in non-brain and brain tissues from additional 1189 
eQTL repositories87. We searched for proxies to our index SNPs with a r2>0.8 using the 1190 
European population reference in rAggr (1000G, phase 1, Mar 2012), and then queried 1191 
index and proxy SNPs against eQTLs from diverse databases.88 Blood cell related eQTL 1192 
studies included fresh lymphocytes and leukocytes, leukocyte samples in individuals with 1193 
Celiac disease, whole blood samples, lymphoblastoid cell lines (LCL) derived from 1194 
asthmatic children, HapMap LCL from 3 populations, a separate study on HapMap CEU LCL, 1195 
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LCL population samples, neutrophils, CD19+ B cells, primary PHA-stimulated T cells, CD4+ 1196 
T cells, peripheral blood monocytes, long non-coding RNAs in monocytes and CD14+ 1197 
monocytes before and after stimulation with LPS or interferon-gamma, CD11+ dendritic 1198 
cells before and after Mycobacterium tuberculosis infection and a separate study of 1199 
dendritic cells before or after stimulation with lipopolysaccharide (LPS), influenza or 1200 
interferon-beta; micro-RNA QTLs, DNase-I QTLs, histone acetylation QTLs, and ribosomal 1201 
occupancy QTLs were also queried for LCL; splicing QTLs and micro-RNA QTLs were 1202 
queried in whole blood. Non-blood cell tissue eQTL searches included omental and 1203 
subcutaneous adipose, visceral fat stomach, endometrial carcinomas, ER+ and ER- breast 1204 
cancer tumor cells, liver, osteoblasts, intestine and normal and cancerous colon, skeletal 1205 
muscle, breast tissue (normal and cancer), lung, skin, primary fibroblasts, sputum, 1206 
pancreatic islet cells, prostate, rectal mucosa, arterial wall and heart tissue from left 1207 
ventricles and left and right atria. Micro-RNA QTLs were also queried for gluteal and 1208 
abdominal adipose and liver. Methylation QTLs were queried in pancreatic islet cells. 1209 
Further mRNA and micro-RNA QTLs were queried from ER+ invasive breast cancer 1210 
samples, colon-, kidney renal clear-, lung- and prostate-adenocarcinoma samples. Brain 1211 
eQTL studies included brain cortex, cerebellar cortex, cerebellum, frontal cortex, gliomas, 1212 
hippocampus, inferior olivary nucleus (from medulla), intralobular white matter, occiptal 1213 
cortex, parietal lobe, pons, pre-frontal cortex, putamen (at the level of anterior 1214 
commussure), substantia nigra, temporal cortex, thalamus and visual cortex. eQTL data 1215 
was integrated from online sources including ScanDB89, the GTEx Portal90, and the 1216 
Pritchard Lab91. Cerebellum, parietal lobe and liver eQTL data was downloaded from 1217 
ScanDB and cis-eQTL were limited to those with P<1.0 × 10-6 and trans-eQTLs with P < 5.0 1218 
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× 10-8. Results for GTEx Analysis V6 for 48 tissues were downloaded from the GTEx Portal 1219 
(www.gtexportal.org). For all gene-level eQTL, if at least 1 SNP passed the tissue-specific 1220 
empirical threshold in GTEx, the best SNP for that eQTL was always retained.  1221 
 1222 
Associations of cognition and neuropathology phenotypes with gene expression in 1223 
brain 1224 
We further related cognitive function and neuropathological findings to the expression 1225 
of the 199 gene set influencing subcortical volumes in 508 brains from the ROSMAP 1226 
samples.  1227 
Briefly, brain autopsies were performed as previously described and each brain was 1228 
inspected for common pathologies relating to loss of cognition in aging populations92,93. In 1229 
this report, we included: neurofibrillary tangles, neuritic plaques, β-amyloid load, tau 1230 
density, hippocampal sclerosis, Lewy bodies and neuronal loss in substantia nigra. 1231 
Neurofibrillary tangles and neuritic plaques were visualized by modified Bielschowsky 1232 
silver stain, then counted and scaled in five brain regions: mid-frontal, temporal, inferior 1233 
parietal, entorhinal cortex, and hippocampus CA1. Composite scores for each of these three 1234 
pathology types were derived by scaling the counts within each of the five regions, and 1235 
taking the square root of the average of the regional scaled values to account for their 1236 
positively skewed distribution92-94. β-amyloid load and tau tangle density were measured 1237 
by immunohistochemistry and square root transformed as previously described95. Lewy 1238 
bodies were identified using immunohistochemistry and were further dichotomized as 1239 
present or absent based on the recommendations of the Report of the Consortium on DLB 1240 
International Workshop96. Hippocampal sclerosis was recorded as either present or absent 1241 
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as evaluated with H&E stain. Nigral neuronal loss was assessed in the substantia nigra in 1242 
the mid to rostral midbrain near or at the exit of the 3rd nerve using H&E stain and 6 1243 
micron sections using a semi-quantitative scale (0–3)97. 1244 
Global cognition was computed as a composite score of 19 (ROS) and 17 (MAP) 1245 
cognitive tests performed at annual evaluations including five cognitive domains: episodic 1246 
memory, semantic memory, working memory, perceptual speed, and visuospatial 1247 
ability92,93. From these scores, we created normalized summary measures to limit the 1248 
influence of outliers. We used global cognition proximate to death to derive cognitive 1249 
reserve. Separately, the residual slope of global cognitive change and the residual slopes of 1250 
cognitive change in the five cognitive domains were derived through general linear mixed 1251 
models, controlling for age at enrollment, sex, and education. 1252 
 1253 
Phenotypic and genetic correlations 1254 
We estimated the Pearson's partial phenotypic correlations among the volumes of 1255 
subcortical structures in 894 participants from the Framingham Heart Study. Similarly, to 1256 
the GWA, these analyses were corrected for the effects of sex, age, age², total intracranial 1257 
volume and PC1.  1258 
Genetic correlation analyses were performed using LDSC regression methods81. The 1259 
GWA meta-analysis results for the seven subcortical brain structures were correlated with 1260 
each other’s, as well as with published GWA studies on the following traits: hippocampal 1261 
volume20, intracranial volume21, white matter hyperintensities22, stroke subtypes23, adult 1262 
height and body mass index24, fat-free mass and whole-body water mass98, Alzheimer’s 1263 
Satizabal et al. 
 
65 
 
disease26, Parkinson’s Disease27, general cognitive function25, bipolar disorder and 1264 
schizophrenia28, and ADHD29. 1265 
 1266 
Look-up of functional orthologs in Drosophila melanogaster 1267 
For the cross-species assessment of gene-phenotype relationships in Drosophila, we 1268 
relied on a similar analytic approach as in prior work99. Human genes were mapped to 1269 
corresponding Drosophila orthologs using DIOPT: Drosophila Integrated Ortholog 1270 
Prediction Tool (www.flyrnai.org/diopt)100, which incorporates 14 distinct algorithms to 1271 
define orthology. Fly gene orthologs were defined based on a DIOPT score of 2 or greater, 1272 
indicating at least 2 algorithms were in agreement on the pairing. When more than one of 1273 
the fly ortholog was predicted, all such genes meeting this threshold were included in our 1274 
analyses. This resulted in a gene set consisting of 168 Drosophila homologs of human 1275 
candidate genes at subcortical volume susceptibility loci. The resulting 37 genes associated 1276 
with “neuroanatomy defective” phenotypes in Drosophila (22%) were annotated based on 1277 
the controlled vocabulary terms implemented in FlyBase (flybase.org/)101. Genes causing 1278 
"neuroanatomy defective" phenotypes in Drosophila include both loss- or gain-of-function 1279 
genetic manipulations of fly gene homologs. Loss-of-function studies included both 1280 
classical mutant alleles (e.g. point mutations, gene deletions, or transposon insertions) or 1281 
gene knockdown using RNA interference transgenic strains. Gain-of-function experiments 1282 
were based on tissue specific overexpression of the fly gene orthologs. The hypergeometric 1283 
overlap test was used to assess for enrichment of “neuroanatomy defective” phenotypes 1284 
among the conserved gene set. 1285 
 1286 
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Protein-protein interactions and network analysis 1287 
We used the human STRING database resource (string-db.org)32 for the exploration of 1288 
direct (physical) and indirect (functional) protein-protein interactions based on the gene 1289 
set derived from the GWA results and functional annotations (Supplementary Table 13). 1290 
The input parameters included a medium-confidence interaction scores (0.4) with first and 1291 
second shells of maximum 5 interactors. Finally, we generated a protein-protein 1292 
interaction network based on known and predicted interactions. 1293 
 1294 
Partitioning heritability 1295 
Partitioned heritability was estimated with stratified LDSC methods30. This method 1296 
partitions SNP heritability using GWAS summary results and accounting by LD. We used 1297 
the meta-analysis results from the European sample to partitioning SNPs by 28 functional 1298 
categories, including: coding, intron, promoter, 3’/5’ UTRs, digital genomic footprint (DGF), 1299 
transcription factor binding sites, chromHMM and Segway annotations for six cell lines, 1300 
DNase I hypersensitivity sites (DHS), H3K4me1, H3K4me3 and H3K9ac marks, two sets of 1301 
H3K27ac marks, super-enhancers, conserved regions in mammals, and FANTOM5 1302 
enhancers. Significance was set at P < (0.05/(28 x 6)) = 3 × 10-4.  1303 
 1304 
Data availability 1305 
The genome-wide summary statistics that support the findings of this study will be made 1306 
available through the CHARGE dbGaP (accession number phs000930) and ENIGMA 1307 
(http://enigma.ini.usc.edu/research/download-enigma-gwas-results) websites. 1308 
 1309 
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